Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 7/2013

01-07-2013 | Short Communication

Resolutive pulmonary endarterectomy in a non-compliant patient with systemic lupus erythematosus and antiphospholipid syndrome

Authors: Anna Kuzenko, Savino Sciascia, Erika Silvestro, Iuliana Badiu, Marco Morsolini, Maria Elena Rovere, Maria Tiziana Bertero

Published in: Rheumatology International | Issue 7/2013

Login to get access

Abstract

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have poor prognosis, and pulmonary endarterectomy (PEA) is considered the treatment of choice for this condition. We report a case and review the literature of successful PEA for CTEPH due to antiphospholipid syndrome associated with systemic lupus erythematosus. The definitive and decisive approach needed to treat this high-risk patient with a history of comorbidity, long-term illness and poor compliance was found with a therapy of PEA.
Literature
1.
Cervera R, Boffa MC, Khamashta MA, Hughes GR (2009) The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus 18:889–893PubMedCrossRef
2.
Pope J (2008) An update in pulmonary hypertension in systemic lupus erythematosus—do we need to know about it? Lupus 17:274–277PubMedCrossRef
3.
Lei YX, Zhang X, Cui Y, Dong GF, Luo RQ (2009) Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients. Zhonghua Yi Xue Za Zhi 89:2934–2937PubMed
4.
Piazza G, Goldhaber SZ (2011) Chronic thromboembolic pulmonary hypertension. N Engl J Med 364:351–360PubMedCrossRef
5.
Galiè N, Hoeper MM, Humbert M, Torbicki A et al (2009) Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263PubMedCrossRef
6.
D’Armini AM, Totaro P, Nicolardi S et al (2010) Interact Cardiovasc Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy. Thorac Surg 10:418–422
7.
8.
Oliveira-Santos M, Verani JF, Klumb EM, Albuquerque EM (2011) Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil. Lupus 20:320–329PubMedCrossRef
9.
10.
Duvdevany I, Cohen M, Minsker-Valtzer A, Lorber M (2011) Psychological correlates of adherence to self-care, disease activity and functioning in persons with systemic lupus erythematosus. Lupus 20:14–22PubMedCrossRef
Metadata
Title
Resolutive pulmonary endarterectomy in a non-compliant patient with systemic lupus erythematosus and antiphospholipid syndrome
Authors
Anna Kuzenko
Savino Sciascia
Erika Silvestro
Iuliana Badiu
Marco Morsolini
Maria Elena Rovere
Maria Tiziana Bertero
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2346-4

Other articles of this Issue 7/2013

Rheumatology International 7/2013 Go to the issue

Letter to the Editors

Posterior ischemic optic neuropathy in a patient with granulomatosis with polyangiitis (Wegener’s)

Letter to the Editors

Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis

Original Article

Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats

Original Article

Impact of physical and psychosocial factors on disability caused by lumbar pain amongst fishing sector workers

Original Article

Seizures in systemic sclerosis

Original Article

The effect of TNF-alpha blockers on psychometric measures in ankylosing spondylitis patients: a preliminary observation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits